1/1

Export Ready

Ruxolitinib Rutinib Cream 1.5%

Name: Ruxolitinib Rutinib Cream 1.5%
SKU: 8495595
Price: 96.35 USD
Availability: InStock

Sold by BALAJI PHARMA · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 96.35 /Tube

In stock

Inclusive of all taxes

Minimum order: 1 Tube

Export Snapshot

MOQ

1 Tube

Lead time

On request

Packaging

Available in hygienic cream tubes (size varies per supplier)

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for BALAJI PHARMA.

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

BALAJI PHARMA

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ruxolitinib Rutinib Cream 1.5% is a prescription topical treatment for skin conditions like eczema and vitiligo. By inhibiting JAK enzymes, it reduces inflammation and aids in skin repigmentation. Proper application as directed by a healthcare provider is essential for effectiveness and safety. This cream is produced following rigorous quality standards to ensure patient well-being.

Product Description

Ruxolitinib Rutinib Cream 1.5% is a topical medication used to treat certain skin conditions such as atopic dermatitis (eczema) and vitiligo. Ruxolitinib, the active ingredient, is a Janus kinase (JAK) inhibitor that works by modulating the immune response, thereby reducing inflammation and skin depigmentation. The cream is applied directly to the affected areas as prescribed by a healthcare professional. Patients should follow the application guidelines to achieve optimal results and minimize potential side effects. Manufactured under strict quality controls, Ruxolitinib Rutinib Cream ensures safety and effectiveness for dermatological use.

Description provided by BALAJI PHARMA.

Specifications

Dosage Form	Cream
Concentration	1.5% Ruxolitinib
Indications	Treatment of atopic dermatitis and vitiligo
Mechanism of Action	JAK enzyme inhibition to modulate immune responses
Administration Route	Topical
Packaging	Available in hygienic cream tubes (size varies per supplier)
Storage Conditions	Store at controlled room temperature, away from direct sunlight
Shelf Life	Typically 24 months or as per manufacturer guidelines
Regulatory Status	Prescription-only medication

Use cases

Category	Pharmaceuticals > Dermatologicals > Topical Medications > Prescription JAK Inhibitor Creams
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Available in hygienic cream tubes (size varies per supplier)
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Tube
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ruxolitinib Rutinib Cream 1.5%. Answers compiled from verified sellers' commercial terms and platform data.

Q: What skin conditions is Ruxolitinib Rutinib Cream 1.5% specifically indicated for?

A: It is specifically indicated for the treatment of inflammatory skin conditions such as atopic dermatitis (eczema) and vitiligo to reduce inflammation and aid in skin repigmentation.

Q: How does Ruxolitinib in the cream work to improve vitiligo?

A: Ruxolitinib acts as a Janus kinase (JAK) inhibitor that modulates immune activity, which reduces inflammation and helps restore pigmentation by promoting repigmentation of depigmented skin patches.

Q: Is a prescription required to supply Ruxolitinib Rutinib Cream 1.5%?

A: Yes, this product is a prescription-only medication and should be supplied and used under healthcare professional guidance.

Q: What are the recommended storage conditions for this cream to maintain its efficacy?

A: The cream should be stored at controlled room temperature away from direct sunlight to preserve its stability and effectiveness.

Q: Can Ruxolitinib Rutinib Cream 1.5% be applied over large body areas?

A: Application over large skin areas should be done under medical supervision to avoid potential systemic absorption and side effects; typically, it is applied only to affected areas as prescribed.

Q: Are there any special manufacturing standards complied with during production?

A: Yes, the cream is manufactured under strict quality control standards ensuring safety, potency, and consistency for dermatological use.

Question not answered? Ask sellers directly — typical response within 4 hours.